Our strategies for fighting severe acute respiratory syndrome (SARS).
Zhong
Nan Shan
NS
Guangzhou Institute of Respiratory Disease, First Affiliated Hospital, Guangzhou Medical College, 51 Yanjiang Road, Guangzhou, China 510120. nanshan@vip.163.com
Zeng
Guang Qiao
GQ
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002681:China / Q000453:epidemiology; D003131:Combined Modality Therapy; D003140:Communicable Disease Control / Q000379:methods; D016358:Contact Tracing; D003937:Diagnosis, Differential; D004196:Disease Outbreaks / Q000517:prevention & control / Q000706:statistics & numerical data; D005334:Fever / Q000382:microbiology; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008478:Mediastinal Emphysema / Q000382:microbiology; D008487:Medical History Taking; D010102:Oxygen Inhalation Therapy; D011030:Pneumothorax / Q000382:microbiology; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D013256:Steroids
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D013256:Steroids